Testing effectiveness (Phase 2)UnknownNCT04169399What this trial is testingToripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTTWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 30
Not applicableUnknownNCT03914352What this trial is testingA Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic ResectionWho this might be right forHepatocellular Carcinoma Cancer Hospital of Guangxi Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07776080What this trial is testingIparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor ThrombusWho this might be right forHCC - Hepatocellular Carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Large-scale testing (Phase 3)Ended earlyNCT01887717What this trial is testingEfficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal VeinWho this might be right forHepatocellular Carcinoma Boston Scientific Corporation 36
Not applicableActive Not RecruitingNCT06248528What this trial is testingComparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.Who this might be right forHepatocellular Carcinoma Chen Xiaoping 1,076
Post-approval studies (Phase 4)UnknownNCT04127396What this trial is testingLenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTTWho this might be right forCarcinoma, HepatocellularPortal Vein Tumor Thrombus Beijing Ditan Hospital 72
Large-scale testing (Phase 3)UnknownNCT04025437What this trial is testingNeoadjuvant Radiotherapy for HCC Involving Type I PVTTWho this might be right forHepatocellular Carcinoma Guangxi Medical University 214
Not applicableUnknownNCT06061445What this trial is testingRadiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular CarcinomaWho this might be right forStage IIIA Hepatocellular Carcinoma Fujian Cancer Hospital 22
Testing effectiveness (Phase 2)UnknownNCT04135690What this trial is testingHAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 60
Testing effectiveness (Phase 2)UnknownNCT01834963What this trial is testingP2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.Who this might be right forHepatocellular Carcinoma Kansai Hepatobiliary Oncology Group 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363512What this trial is testingEfficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor ThrombusWho this might be right forHCC - Hepatocellular Carcinoma Henan Cancer Hospital 27
Not applicableUnknownNCT03730675What this trial is testingIrradiation Stent Placement Plus TACE for HCC and PVTTWho this might be right forHepatocellular CarcinomaPortal Vein Tumor Thrombosis Zhongda Hospital 308
Testing effectiveness (Phase 2)Study completedNCT01911000What this trial is testingEffectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor ThrombosisWho this might be right forCarcinoma. Hepatocellular Samsung Medical Center 69
Testing effectiveness (Phase 2)Looking for participantsNCT06166576What this trial is testingRadioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor ThrombosisWho this might be right forHepatocellular Carcinoma Seoul National University Hospital 30
Not applicableWithdrawnNCT05592197What this trial is testingSafety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTTWho this might be right forAdvanced Hepatocellular Carcinoma Sun Yat-sen University
Testing effectiveness (Phase 2)Looking for participantsNCT07062055What this trial is testingBITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or OligometastasesWho this might be right forHepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more Shandong Cancer Hospital and Institute 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05286320What this trial is testingPhase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.Who this might be right forUnresectable Hepatocellular CarcinomaPembrolizumabLenvatinib+1 more National Taiwan University Hospital 27
Testing effectiveness (Phase 2)Looking for participantsNCT07122089What this trial is testingEvaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein ThrombosisWho this might be right forHepatocellular Carcinoma Non-resectable Center Eugene Marquis 80